{"url_path":"/sec/tcrx/8-k/2026-06-22/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1783328/0001193125-26-276693-index.html","accession_number":"0001193125-26-276693","cik":"0001783328","ticker":"TCRX","issuer_name":"TScan Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1783328/0001193125-26-276693-index.html","primary_entity_key":"0001783328","primary_entity_name":"TScan Therapeutics, Inc."},"word_count":84,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits:\n\n \n\nExhibit\n\n No. \n\n  \n\nDescription\n\n99.1\n  \n[Press release, dated June 22, 2026](d103234dex991.htm)\n\n99.2\n  \n[Company Presentation, dated June 22, 2026](d103234dex992.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nTScan Therapeutics, Inc.\n\nDate: June 22, 2026\n \n\n \nBy:\n \n\n/s/ Gavin MacBeath\n\n \n\n \n\n \nGavin MacBeath\n\n \n\n \n\n \nChief Executive Officer"}